FINHUB Insights

TMO · Q2 FY25 · Mar 30 – Jun 28, 2025

Thermo Fisher Scientific Q2 FY25: where the revenue came from and where it went

Thermo Fisher Scientific Q2 FY25: revenue $10.9B (+3% year over year). Net profit $1.6B. Largest cohort Consumables $4.6B. The whole income statement as a sankey diagram from the SEC filing.

Period
Mar 30 – Jun 28, 2025
Reported
Aug 1, 2025 10-Q
Sankey diagram of Thermo Fisher Scientific's income statement for Q2 FY25: revenue of $10.9 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$10.9B +3% year over year
Gross profit$4.2B 39% margin
Operating profit$1.8B 17% margin
Net profit$1.6B 15% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 28, 2025).
ItemValueShare of revenueYear over year
Revenue 10.9 100% +3%
Consumables 4.6 42% +6%
Service 4.6 42% +5%
Instruments 1.6 15% −9%
Cost of revenue−6.661%
Gross profit4.239% margin−1pp
Research & development−0.43%+0pp
SG&A−220%+0pp
Operating profit1.817% margin+0pp
Tax−0.1
Interest & other costs−0.1
Net profit1.615%+0pp
Filing on EDGAR More quarters of TMO

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters